vaccinogeninc.investorroom.com vaccinogeninc.investorroom.com

vaccinogeninc.investorroom.com

Investor Welcome - Vaccinogen

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX, an immunotherapy for Stage II colon cancer. May 5, 2015. Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board. Feb 24, 2015.

http://vaccinogeninc.investorroom.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR VACCINOGENINC.INVESTORROOM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 2.5 out of 5 with 6 reviews
5 star
0
4 star
1
3 star
3
2 star
0
1 star
2

Hey there! Start your review of vaccinogeninc.investorroom.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.5 seconds

FAVICON PREVIEW

  • vaccinogeninc.investorroom.com

    16x16

  • vaccinogeninc.investorroom.com

    32x32

  • vaccinogeninc.investorroom.com

    64x64

  • vaccinogeninc.investorroom.com

    128x128

CONTACTS AT VACCINOGENINC.INVESTORROOM.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Welcome - Vaccinogen | vaccinogeninc.investorroom.com Reviews
<META>
DESCRIPTION
Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX, an immunotherapy for Stage II colon cancer. May 5, 2015. Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board. Feb 24, 2015.
<META>
KEYWORDS
1 menu
2 mission statement
3 background
4 our solution
5 vaccinogen
6 about vaccinogen
7 leadership
8 board of directors
9 medical advisory board
10 events
CONTENT
Page content here
KEYWORDS ON
PAGE
menu,mission statement,background,our solution,vaccinogen,about vaccinogen,leadership,board of directors,medical advisory board,events,personalized immunotherapy,why personalization,how oncovax works,oncovax,about oncovax,clinical results,manufacturing
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Welcome - Vaccinogen | vaccinogeninc.investorroom.com Reviews

https://vaccinogeninc.investorroom.com

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX, an immunotherapy for Stage II colon cancer. May 5, 2015. Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board. Feb 24, 2015.

INTERNAL PAGES

vaccinogeninc.investorroom.com vaccinogeninc.investorroom.com
1

Investor Alerts - Vaccinogen

http://vaccinogeninc.investorroom.com/investor-alerts

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Get News Alerts by Email. Get News Alerts by Email. If youre a working journalist that works out of a newsroom location, youll see our news come in over the wire. If you happen to be working from home or are interested in a more direct way of receiving our news releases, we offer you two distinct and automated options.

2

Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board - May 5, 2015

http://vaccinogeninc.investorroom.com/2015-05-05-Vaccinogen-Names-Co-Founder-and-CEO-Andrew-L-Tussing-as-Chairman-of-the-Board

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board. Benjamin S. Carson, Sr., MD Steps Down from Board of Directors, Chairman Role and Medical Advisory Board to Focus on His Candidacy for the Republican Presidential Nomination. May 5, 2015. May 5, 2015. Via the Republican nomination. Vaccinogen e...

3

Corporate Governance - Vaccinogen

http://vaccinogeninc.investorroom.com/corporate-governance

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. The Board of Directors of Vaccinogen, Inc. has established the following document to serve as a guideline for the conduct and operation of the Board and all matters related to proper corporate governance. Corporate Governance Guidelines Vaccinogen 11-25-14.pdf. 949 Fell Street, 2nd Floor. Baltimore, MD 21231.

4

Vaccinogen Relocates Corporate Headquarters to Baltimore - Feb 24, 2015

http://vaccinogeninc.investorroom.com/2015-02-24-Vaccinogen-Relocates-Corporate-Headquarters-to-Baltimore

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen Relocates Corporate Headquarters to Baltimore. Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX clinical trial. Feb 24, 2015. Feb 24, 2015. To a 10,000 square-foot facility at 949 Fell Street in Baltimore, MD. The relocation was completed on February 22. Tranche...

5

News - Vaccinogen

http://vaccinogeninc.investorroom.com/news

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below. Get News Alerts by Email. Jun 16, 2016. Vaccinogen Announces Filing of Oncavert Patent Application. Dec 2, 2015.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

chinesefn.com chinesefn.com

中文投資網

http://www.chinesefn.com/V2013/aboutus.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG). 美國中文投資網有限公司(chineseinvestors.com Inc)成立於1999年, 創始人Warren王1996年在美國投資銀行上班時,發現了網路科技的巨大潛力和未來,決定在1999年自行創業,專為華人提供投資教育服務和交易平臺服務,現在中文投資網在美國丹佛,中國上海等地都設有辦事處,提供包括美國股票,美股期權,黃金,外匯等金融產品的投資交易教育服務。

chinesefn.com chinesefn.com

美股_中文投資網為全球華人提供美股最新資訊和美國股票交易技巧

http://www.chinesefn.com/onecard.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG).

chineseinvestors.com chineseinvestors.com

美股_中文投資網為全球華人提供美股最新資訊和美國股票交易技巧

http://www.chineseinvestors.com/V2013/News_List.chtml?type=YB1

Trading for a Living DVD. Ubiquity, Inc. (UBIQ). IFM Investments Limited (CTC). China YCT Group (CYIG).

chineseinvestors.com chineseinvestors.com

美股_中文投資網為全球華人提供美股最新資訊和美國股票交易技巧

http://www.chineseinvestors.com/index.chtml

Trading for a Living DVD. Ubiquity, Inc. (UBIQ). IFM Investments Limited (CTC). China YCT Group (CYIG). CIIX 30指數 ( 點擊看大圖.

chineseinvestors.com chineseinvestors.com

美股_中文投資網為全球華人提供美股最新資訊和美國股票交易技巧

http://www.chineseinvestors.com/V2013/News_List.chtml?type=B11

Trading for a Living DVD. Ubiquity, Inc. (UBIQ). IFM Investments Limited (CTC). China YCT Group (CYIG).

chinesefn.com chinesefn.com

中文投資網

http://www.chinesefn.com/V2013/partner.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG). Chineseinvestors.com Inc is an independent membership service that specializes in providing information on stocks that in the opinion of Chineseinvestors.com has investment potential. Chineseinvestors.com Inc may has positions in some of the stocks discussed on the site or in email alerts and is under no obligation to disclose the size of the position or the time that it was acquired. 美國中文投資網 Chineseinvestors.com Inc...

chinesefn.com chinesefn.com

中文投資網

http://www.chinesefn.com/V2013/ad.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG). Chinesefn.com is a dynamic Financial Web site that caters to Chinese Investors with the best in financial commentary and analysis. We offer timely market information of US publicly traded stocks and foreign currency with free quotes, charts, market news, and links to research . We are designed for Chinese Investors who are seeking trustworthy market information to help them make informed investment decisions. Chinese wor...

chinesefn.com chinesefn.com

中文投資網

http://www.chinesefn.com/V2013/disclaim.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG). According to SEC regulation, we need to disclose, to the Minimum that. 1 We are not professional financial advisors. 2 Our site and all publishing are for entertainment only. 3 We may or may not buy or sell the securities mentioned in our publication. 4 All subscribers should consult their own financial advisors regarding any securities transaction, and be responsible for their own investment decisions. Investors should ...

chinesefn.com chinesefn.com

中文投資網

http://www.chinesefn.com/v2013/calc_helpb.chtml

Trading for a Living DVD. Ubiquity, Inc.(UBIQ). China YCT International Group(CYIG).

UPGRADE TO PREMIUM TO VIEW 28 MORE

TOTAL LINKS TO THIS WEBSITE

37

SOCIAL ENGAGEMENT



OTHER SITES

vaccinogen.org vaccinogen.org

Vaccinogen.org

vaccinogen.us vaccinogen.us

Vaccinogen.us

vaccinogenasia.com vaccinogenasia.com

Vaccinogenasia.com

vaccinogenchina.com vaccinogenchina.com

Vaccinogenchina.com

vaccinogeninc.com vaccinogeninc.com

Vaccinogen Treating Colon Cancer with OncoVAX Immunotherapy

Andrew L. Tussing. Michael G. Hanna, Jr., Ph.D. Peter Morsing, Ph.D. Jason D. Howard, Ph.D. Earl V. Miller, MBA. Drs Dinand van der Linde, MSc, MA. HC Hoover, Jr., M.D. Andrew L. Tussing. Michael G. Hanna, Jr., Ph.D. Human Monoclonal Antibodies (HuMabs) Program. OncoVax Fact Sheet (PDF). Vaccines in Immunotherapy of Cancer: OncoVAX Overview Part 1. Vaccines in Immunotherapy of Cancer: OncoVAX Overview Part 2. Manufacturing - Stage 1. Manufacturing - Stage 2. Manufacturing - Stage 3. Stage III Colon Cancer.

vaccinogeninc.investorroom.com vaccinogeninc.investorroom.com

Investor Welcome - Vaccinogen

Human Monoclonal Antibodies (HuMabs) Program. OncoVAX For Colon Cancer. Stage III Colon Cancer. Additional Potential OncoVAX applications. Human Monoclonal Antibodies (HuMabs) Program. Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body’s own immune system. It is the producer of OncoVAX, an immunotherapy for Stage II colon cancer. May 5, 2015. Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board. Feb 24, 2015.

vaccinogeninc.net vaccinogeninc.net

Vaccinogeninc.net

vaccinogeninc.org vaccinogeninc.org

Vaccinogeninc.org

vaccinologie.edimark.tv vaccinologie.edimark.tv

Edimark TV - L'actualité des spécialités médicales en vidéo

Vous devez vous identifier pour accéder à cette fonction. Mot de passe* :. Rester connecté :. Mot de passe oublié? MOT DE PASSE OUBLIÉ? Infections à Clostridium difficile. Infections à Clostridium difficile. Infections à Clostridium difficile. L'actualité médicale en vidéo. Epidémiologie de la SEP : une révolution! ICD : une pathologie souvent difficile à vivre! Comment annoncer la maladie? Droit européen : un droit supranational. ECCMID 2014 : quelle antibiothérapie prescrire dans les ICD?

vaccinologie.org vaccinologie.org

Cours international francophone de vaccinologie

Accueil Cours de Vaccinologie. Faute d'un nombre suffisant d'inscrits en 2015, le prochain Cours international francophone de vaccinologie se déroulera à l'École du Val-de-Grâce. La 8è Journée Jean-Gérard Guillet de vaccinologie clinique aura par contre bien lieu le jeudi 2 avril 2015. Le CIFV permet sous certaines conditions l'obtention d'un diplôme universitaire et la validation d'un module du Master professionnel Mention Santé Publique, Spécialité Santé Internationale. Page lue en 0,0090 seconde (7/0).

vaccinologie.ro vaccinologie.ro

Vaccinologie.ro | Grup Vaccinologie

Vaccinarea reprezinta unul din cele mai importante mijloace de prevenire in domeniul medical pe care omenirea le-a cunoscut de la cunoscut de la inceputuri incoace. Procesul de vaccinare a salvat. Fisa: Gripa si sarcina. Gripa poate deveni extrem de periculoasa pe durata sarcinii Gripa este intotdeauna un fenomen neplacut, dar poate fi, in acelasi timp, destul de usoara si poate trece repede, in cazul anumitor. 10 pasi pentru promovarea va. Vaccinarea reprezinta unul din cele mai importante. Grupul de va...